Brokerages Set Prime Medicine, Inc. (NYSE:PRME) Price Target at $13.38
Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have earned a consensus rating of “Buy” from the ten brokerages that are presently covering the firm, MarketBeat reports. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective […]
Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have earned a consensus rating of “Buy” from the ten brokerages that are presently covering the firm, MarketBeat reports. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective […]
